The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App 
Professionals >> Visit The Body PROThe Body en Espanol
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

ADAP Threatened By Inadequate Funding:
Other AIDS Programs at Risk Due to Magnitude of Problem

September 9, 1996

WASHINGTON, D.C. Fifteen years into the AIDS epidemic, the fragile health care system created to assist people with HIV may well be in imminent danger of collapse under the weight of new and expensive therapies designed to extend and enhance the lives of those living with HIV and AIDS. The magnitude of this change in standard of care has forced the 50-state network of AIDS Drug Assistance Programs (ADAP) to cap enrollments, severely restrict access to the latest life-enhancing and extending drugs, or drastically cut the number of drugs available to patients.

From Washington state to Washington, D.C., virtually every state is bearing the burden of explosive increases in ADAP enrollment and the demand for expensive combination drug therapies. While some states have been forced to restrict access to AIDS therapies, others (such as Washington, D.C.,) face a total cessation of drug distribution because of inadequate funding.

"In the short term, the ADAP system must be infused with enough cash to effectively operate. Otherwise, drug assistance programs nationwide will continue to operate in a state of perpetual crisis," said Gary Rose, AIDS Action's treatment and research legislative representative. "Every state ADAP program in crisis means tens of thousands of uninsured or underinsured people with HIV and AIDS will be denied access to drugs that could help them live longer and healthier lives."

Budget projections issued by the ADAP Working Group - an historic collaboration of national and regional AIDS organizations and the pharmaceutical industry dedicated to working with Congress and the federal government to find solutions to the crisis in access to new AIDS therapies - suggest that ADAP programs will require at least $200 million federal dollars and $60 million state dollars to provide the drugs needed to treat HIV disease for uninsured and underinsured patients.

"We have about four weeks to work with the Clinton Administration and Congress to make this funding available before Washington shuts down for election '96." Rose said. "Before President Clinton and members of Congress hit the campaign trail, they should ensure that Americans living with HIV and AIDS are effectively cared for. It's difficult to cast a vote when you're too sick to get out of bed."

While emergency fiscal year 1997 funding will save lives, Rose said, it remains a short-term solution. Without a stable funding base, states will continue to slash their drug formularies, place caps on drug enrollment programs and, quite possibly, shut down their programs temporarily when their resources have been spent.

Rose said, the AIDS community is grateful to the Clinton Administration for their speedy response to the ADAP crisis - $52 million in fiscal year 1996 funding and a request of $65 million for fiscal year 1997. Unfortunately, he added, the magnitude of this revolution in care will require much more. AIDS Action calls on Congress and the administration to appropriate desperately needed funds for state ADAP programs (short term) and to exhibit continued leadership in ensuring real access to health care for the uninsured and underinsured (long term). Additionally, President Clinton must maintain his commitment to the Medicaid program by ensuring that any attempts at reforms consider the needs of people living with HIV.

Finally, Rose explained, we cannot let the drama of the ADAP crisis collapse the fragile structures created over the last 15 years to cope with this expanding epidemic. AIDS Action calls upon the federal government to unwaveringly support:

  1. The underlying titles of the Ryan White CARE Act: Without these vital services provided by the CARE Act, people living with HIV and AIDS will lack access to a continuum of care necessary to take full advantage of new therapies or to be cared for if the therapies fail. In addition, Title V of the CARE Act funds the AIDS Education Training Centers (AETCs) , the best method available for getting information on how to use these therapies to physicians.
  2. Housing Opportunities for People With AIDS (HOPWA): People who are homeless or at risk of becoming homeless will find it difficult, if not impossible, to comply with the difficult regimens required by new therapies. AIDS Action enthusiastically supports the administration's request for $15 million in new HOPWA funding.
  3. Prevention: The least expensive way to treat this disease still lies in its prevention of new infections. The federal government must continue its support for prevention programs that are designed and implemented by local communities.
  4. Research: Protease inhibitors are not a cure. In order to find the next generation of treatments for HIV disease, the federal government must maintain its support for AIDS research at the National Institutes of Health (NIH) and for the consolidated budget authority of the Office of AIDS Research (OAR).

For more information, contact:
AIDS Action Council
1875 Connecticut Avenue NW #700
Washington DC 20009
202-986-1300, extension 3053
202-986-1345 (fax)
202-332-9614 (tty)

  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

This article was provided by AIDS Action Council.